Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sequent Medical Inc.

Division of Terumo Corp.

Latest From Aventis SA

ESSA Pharma Will Fit Into Xtandi, Zytiga Prostate Cancer Treatment Gaps

Emerging Company Profile: ESSA Pharma, a publically traded cancer R&D company, believes it has the answer to drug resistance in patients treated with best-selling cancer therapies Xtandi and Zytiga – as it targets last-line patients with a prostate cancer therapy based on a new mechanism of action.

StartUps and SMEs Research & Development

Asia On The Move: Sanofi China GM Moves To Japan

The fall season ushers in a flurry of personnel changes at Sanofi, Amgen and Astellas.

BioPharmaceutical China

Asia On The Move: AZ Hires Roche Exec, BMS Names India Head

Roche’s pharma regional vice-president for Asia has left for AstraZeneca and Merck & Co’s emerging market R&D head steps down. Personnel changes also take place at BMS India, Kyowa Hakko Kirin and the US Pharmacopeia Convention.

BioPharmaceutical China

Washington Threatens; Wall Street Reacts

The biotech investment boom hit the brakes at the end of the first quarter when Rep. Henry Waxman (D-Calif.) publicly complained about Gilead’s pricing for the hepatitis C therapy Sovaldi. The fact that Waxman’s attack has little substantive impact didn’t seem to matter. Another Washington threat—to undo “tax inversion” strategies—is probably much more real, but may actually boost the sector for the rest of 2014.

BioPharmaceutical Reimbursement
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Terumo Corp.
  • Senior Management
  • Thomas Wilder, Pres. & CEO
    Kevin J Cousins, VP, CFO
    William R Patterson, PhD, VP, R&D & Operations
    Andrew J Hykes, VP, Commercial Operations
    Amy L Walters , VP, Clinical & Reg. Affairs
  • Contact Info
  • Sequent Medical Inc.
    Phone: (949) 830-9600
    11 Columbia
    Aliso Viejo, CA 92656